These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 20953746

  • 1. Hyaluronic acid improves "pleasantness" and tolerability of nebulized hypertonic saline in a cohort of patients with cystic fibrosis.
    Buonpensiero P, De Gregorio F, Sepe A, Di Pasqua A, Ferri P, Siano M, Terlizzi V, Raia V.
    Adv Ther; 2010 Nov; 27(11):870-8. PubMed ID: 20953746
    [Abstract] [Full Text] [Related]

  • 2. Nebulized hypertonic saline containing hyaluronic acid improves tolerability in patients with cystic fibrosis and lung disease compared with nebulized hypertonic saline alone: a prospective, randomized, double-blind, controlled study.
    Furnari ML, Termini L, Traverso G, Barrale S, Bonaccorso MR, Damiani G, Piparo CL, Collura M.
    Ther Adv Respir Dis; 2012 Dec; 6(6):315-22. PubMed ID: 22968159
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hyaluronic acid improves the tolerability of hypertonic saline in the chronic treatment of cystic fibrosis patients: a multicenter, randomized, controlled clinical trial.
    Ros M, Casciaro R, Lucca F, Troiani P, Salonini E, Favilli F, Quattrucci S, Sher D, Assael BM.
    J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):133-7. PubMed ID: 23745525
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pilot Randomized Controlled Trial Evaluating the Effect of Hypertonic Saline With and Without Hyaluronic Acid in Reducing Inflammation in Cystic Fibrosis.
    Brivio A, Conese M, Gambazza S, Biffi A, Tirelli AS, Russo M, Foà M, Colombo C.
    J Aerosol Med Pulm Drug Deliv; 2016 Dec; 29(6):482-489. PubMed ID: 27149365
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pilot study of safety and tolerability of inhaled hypertonic saline in infants with cystic fibrosis.
    Subbarao P, Balkovec S, Solomon M, Ratjen F.
    Pediatr Pulmonol; 2007 May; 42(5):471-6. PubMed ID: 17436328
    [Abstract] [Full Text] [Related]

  • 10. Restoring airway surface liquid in cystic fibrosis.
    Ratjen F.
    N Engl J Med; 2006 Jan 19; 354(3):291-3. PubMed ID: 16421371
    [No Abstract] [Full Text] [Related]

  • 11. Rationale for hypertonic saline therapy for cystic fibrosis lung disease.
    Tarran R, Donaldson S, Boucher RC.
    Semin Respir Crit Care Med; 2007 Jun 19; 28(3):295-302. PubMed ID: 17562499
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Overnight delivery of hypertonic saline by nasal cannula aerosol for cystic fibrosis.
    Corcoran TE, Godovchik JE, Donn KH, Busick DR, Goralski J, Locke LW, Markovetz MR, Myerburg MM, Muthukrishnan A, Weber L, Lacy RT, Pilewski JM.
    Pediatr Pulmonol; 2017 Sep 19; 52(9):1142-1149. PubMed ID: 28737262
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.